The next phase of Kilroy's big Oyster Point project is seeing interest from tech and financial services as well as biotech, ...

DelveInsight's Dry Eye Disease Market Insights report includes a comprehensive understanding of current treatment practices, dry eye ...

The owners of a Bethpage mosque have filed a federal lawsuit against the Town of Oyster Bay and members of its planning advisory board, alleging officials created unreasonable restrictions on the ...

Purdue Pharma To Pay $7.4B In Historic Opioid Settlement: How Much Will NY Get? Purdue Pharma will pay more than $7 billion for the corporation's role in fueling the opioid epidemic that has killed ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

A protein found in the blood–or hemolymph–of the Sydney rock oyster (Saccostrea glomerata ... aquaculture and pharmaceutical industries,” said Benkendorff. “In the meantime, slurping ...

Chinese New Year is just days away, and the festive buzz is in the air. As we prepare to usher in the Year of the Snake, Chinatown Point is pulling out all the stops to make your celebrations extra ...

I’m here to help you pick the best charger no matter your price point. Over the years, I have tested many different forms of charging, from simple wireless pad chargers to 500W power bricks.

In a study published in PLOS ONE, the researchers demonstrate a protein in the blood, or hemolymph, of a Sydney Rock Oyster not only ... aquaculture and pharmaceutical industries," said Professor ...

Super Bowl XXXIX’s logo prominently featured the Dames Point Bridge, an iconic structure in Jacksonville, Fla. These logos continued until 2010, when the NFL shifted its design philosophy again.

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry - where the American market accounts for almost a third of exports - during Donald Trump’s presidency.